Deciphera Pharmaceuticals, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 36 rows, 36 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-09-20: Reporting owner Flynn Daniel Lee; Form 3; Security Series A Preferred Stock; Transaction Holding.
- 2018-09-20: Reporting owner Flynn Daniel Lee; Form 3; Security Series B-1 Preferred Stock; Transaction Holding.
- 2018-09-20: Reporting owner Flynn Daniel Lee; Form 3; Security Series B-2 Preferred Stock; Transaction Holding.
- 2018-09-20: Reporting owner Flynn Daniel Lee; Form 3; Security Series C Preferred Stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-09-20 holding as of filing | Flynn Daniel Lee Officer (Chief Scientific Officer) | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2018-09-20 | ||
| 2018-09-20 holding as of filing | Flynn Daniel Lee Officer (Chief Scientific Officer) | 3 | Series B-1 Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2018-09-20 | ||
| 2018-09-20 holding as of filing | Flynn Daniel Lee Officer (Chief Scientific Officer) | 3 | Series B-2 Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2018-09-20 | ||
| 2018-09-20 holding as of filing | Flynn Daniel Lee Officer (Chief Scientific Officer) | 3 | Series C Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2018-09-20 | ||
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −22,070 0 owned after | $0.00 | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Series B-1 Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −1,494 0 owned after | $0.00 | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Series B-2 Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −1,392 0 owned after | $0.00 | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Series C Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −1,071 0 owned after | $0.00 | 2018-09-20 | |
| 2017-10-02 | New Leaf Venture Associates III, L.P. | New Leaf Ventures III, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf BPO Associates I, L.P. | New Leaf Biopharma Opportunities I, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −148,515 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | New Leaf Venture Associates III, L.P. | New Leaf Ventures III, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf BPO Associates I, L.P. | New Leaf Biopharma Opportunities I, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −198,004 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | New Leaf Venture Associates III, L.P. | New Leaf Ventures III, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf BPO Associates I, L.P. | New Leaf Biopharma Opportunities I, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −49,505 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | New Leaf Venture Associates III, L.P. | New Leaf Ventures III, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf BPO Associates I, L.P. | New Leaf Biopharma Opportunities I, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −198,004 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | New Leaf Venture Associates III, L.P. | New Leaf Ventures III, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf BPO Associates I, L.P. | New Leaf Biopharma Opportunities I, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −65,997 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | Ratcliffe Liam Director, 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −148,515 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | Ratcliffe Liam Director, 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −198,004 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | Ratcliffe Liam Director, 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −49,505 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | Ratcliffe Liam Director, 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −198,004 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | Ratcliffe Liam Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −65,997 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | Brightstar Associates LLC 10% Owner | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,976,134 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | Brightstar Associates LLC 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −297,030 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | Brightstar Associates LLC 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Direct | C Conversion of derivative security | −396,008 0 owned after | $0.00 | 2017-10-02 | |
| 2017-10-02 | Brightstar Associates LLC 10% Owner | 4 | Series C Preferred Stock Derivative · Direct | C Conversion of derivative security | −263,991 0 owned after | $0.00 | 2017-10-02 | |
| 2017-09-28 holding as of filing | Ratcliffe Liam Director, 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Ratcliffe Liam Director, 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Ratcliffe Liam Director, 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Ratcliffe Liam Director, 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Ratcliffe Liam Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | New Leaf BPO Associates I, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf Ventures III, L.P. | New Leaf Biopharma Opportunities I, L.P. | New Leaf Venture Associates III, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | New Leaf BPO Associates I, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf Ventures III, L.P. | New Leaf Biopharma Opportunities I, L.P. | New Leaf Venture Associates III, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | New Leaf BPO Associates I, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf Ventures III, L.P. | New Leaf Biopharma Opportunities I, L.P. | New Leaf Venture Associates III, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | New Leaf BPO Associates I, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf Ventures III, L.P. | New Leaf Biopharma Opportunities I, L.P. | New Leaf Venture Associates III, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | New Leaf BPO Associates I, L.P. | New Leaf Venture Management III, L.L.C. | New Leaf Ventures III, L.P. | New Leaf Biopharma Opportunities I, L.P. | New Leaf Venture Associates III, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Brightstar Associates LLC 10% Owner | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Brightstar Associates LLC 10% Owner | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Brightstar Associates LLC 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Direct | Holding | no price filed | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Brightstar Associates LLC 10% Owner | 3 | Series C Preferred Stock Derivative · Direct | Holding | no price filed | 2017-09-28 |